Apr 13 2024National Comprehensive Cancer Network The National Comprehensive Cancer Network® -;an alliance of leading cancer centers-;hosted more than 1,700 oncology professionals during the NCCN 2024 Annual Conference on April 5-7. The yearly meeting includes opportunities for care providers to interact with world-renowned specialists on the latest evidence-based expert consensus recommendations for delivering high quality, patient-centered cancer care.
The conference included a plenary session on the topic of drug shortages in oncology, with a discussion about both short-term mitigation strategies and long-term fixes. Speakers shared their personal experiences as patients and caregivers in addition to physicians and pharmacists navigating recent and longstanding experiences with concerning shortages of life-saving generic medications.
Congress needs to pass laws mandating more transparency around the supply chain of oncology drugs. If we're going to solve this, lawmakers need to act." Another plenary session provided patient and provider perspectives on managing hereditary cancer risk, such as Lynch syndrome. Related StoriesOther sessions delved into the latest updates to the NCCN Clinical Practice Guidelines in Oncology for numerous cancer types, including: